COVID-19 Vaccine: A comprehensive status report

SP Kaur, V Gupta - Virus research, 2020 - Elsevier
The current COVID-19 pandemic has urged the scientific community internationally to find
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published …

Interferons, interferon‐like cytokines, and their receptors

S Pestka, CD Krause, MR Walter - Immunological reviews, 2004 - Wiley Online Library
Recombinant interferon‐α (IFN‐α) was approved by regulatory agencies in many countries
in 1986. As the first biotherapeutic approved, IFN‐α paved the way for the development of …

[HTML][HTML] Safety, tolerability, and immunogenicity of COVID-19 vaccines: a systematic review and meta-analysis

P Yuan, P Ai, Y Liu, Z Ai, Y Wang, W Cao, X Xia… - MedRxiv, 2020 - ncbi.nlm.nih.gov
We aimed to summarize reliable medical evidence by the meta-analysis of all published
clinical trials that investigated the safety, tolerability, and immunogenicity of vaccine …

[HTML][HTML] Evaluation of the anti-malarial activity of crude extract and solvent fractions of the leaves of Olea europaea (Oleaceae) in mice

D Misganaw, E Engidawork, T Nedi - BMC Complementary and …, 2019 - Springer
Background Drug resistance poses a challenge to malaria control measures. This calls for
discovery & development of new chemotherapeutic agents. This study therefore was …

The role of lymphocytes in the development and treatment of alopecia areata

H Guo, Y Cheng, J Shapiro… - Expert review of clinical …, 2015 - Taylor & Francis
Alopecia areata (AA) development is associated with both innate and adaptive immune cell
activation, migration to peri-and intra-follicular regions, and hair follicle disruption. Both …

[HTML][HTML] Counting on COVID-19 vaccine: insights into the current strategies, progress and future challenges

R Kandimalla, P Chakraborty, J Vallamkondu… - Biomedicines, 2021 - mdpi.com
The emergence of a novel coronavirus viz., severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …

Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach

M Entezam, MJ Sanaei, Y Mirzaei, AH Mer… - Life sciences, 2023 - Elsevier
Gastric cancer (GC) is a severe malignancy, accounting for the third most common cancer
death worldwide. Despite the development of chemo-radiation therapy, there has not been …

The influence of Salvia cadmica Boiss. extracts on the M1/M2 polarization of macrophages primed with Helicobacter pylori lipopolysaccharide in conjunction with NF …

W Gonciarz, E Piątczak, M Chmiela - Journal of Ethnopharmacology, 2023 - Elsevier
Ethnopharmacological relevance The large number of secondary derivatives have been
isolated from the genus Salvia with about 700 species, and used in the pharmacopoeia …

[HTML][HTML] TLRs as a promise target along with immune checkpoint against gastric cancer

L Cui, X Wang, D Zhang - Frontiers in Cell and Developmental Biology, 2021 - frontiersin.org
Gastric cancer (GC) is one of the most common cancers in the world, and the incidence of
gastric cancer in Asia appears to increase in recent years. Although there is a lot of …

[HTML][HTML] Use of immunotherapy in the treatment of gastric cancer

L Yang, Y Wang, H Wang - Oncology letters, 2019 - spandidos-publications.com
Gastric cancer (GC) is a malignant tumor that negatively impacts human health, which
typically presents in the advanced stages of disease in the majority of patients. Despite the …